Canadian efforts to prevent and control hypertension
- PMID: 20847986
- PMCID: PMC2949984
- DOI: 10.1016/s0828-282x(10)71076-x
Canadian efforts to prevent and control hypertension
Abstract
Suboptimum blood pressure is estimated to be the leading risk factor for death worldwide and is associated with 13.5% of deaths globally. The clinical diagnosis of hypertension affects one in four adults globally and is expected to increase by 60% between 2000 and 2025. Clearly, global efforts to prevent and control hypertension are important health issues. While Canada had a prevalence of hypertension similar to that of the United States in the early 1990 s, the treatment and control rate was only 13% compared with 25% in the United States. A national strategic plan was developed, and a coalition of organizations and health care professional and scientist volunteers actively implemented parts of the strategy. Specific initiatives that have evolved include the development of hypertension knowledge translation programs for health professionals, the public and people with hypertension, an outcomes research program to assess the impact of hypertension and guide national-, regional- and community-based knowledge translation interventions, and a program to reduce the prevalence of hypertension by decreasing sodium additives in food. These initiatives have relied on the active involvement of health care professional volunteers, health care professional and scientific organizations and various government departments. There have been large increases in the diagnosis and treatment of hypertension, with corresponding reductions in cardiovascular disease and total mortality associated with the start of the hypertension initiatives. As a result, Canada is becoming recognized as a world leader in the prevention, treatment and control of hypertension.
On estime qu’une tension artérielle sous-optimale est le principal facteur de risque de décès et s’associe à 13,5 % des décès sur la scène mondiale. Le diagnostic clinique d’hypertension touche un adulte sur quatre sur la planète et devrait augmenter de 60 % entre 2000 et 2025. De toute évidence, les efforts mondiaux pour prévenir et contrôler l’hypertension constituent d’importants enjeux de santé. Tandis que le Canada avait une prévalence d’hypertension similaire à celle des États-Unis au début des années 1990, le taux de traitement et de contrôle s’élevait seulement à 13 % par rapport à 25 % aux États-Unis. On a élaboré un plan stratégique national, et une coalition d’organisations et de professionnels de la santé et scientifiques bénévoles ont mis en œuvre des volets de la stratégie. Des initiatives spécifiques ont évolué, dont l’élaboration de programmes de transfert du savoir sur l’hypertension pour les professionnels de la santé, le public et les hypertensifs, un programme de recherche sur les issues pour évaluer les répercussions de l’hypertension et orienter les interventions de transfert du savoir nationales, régionales et communautaires, ainsi qu’un programme pour réduire la prévalence d’hypertension en diminuant les ajouts de sodium dans les aliments. Ces initiatives se fondaient sur la participation active de professionnels de la santé bénévoles, de professionnels de la santé et d’organisations scientifiques ainsi que sur divers ministères du gouvernement. On constate de fortes augmentations du diagnostic et du traitement de l’hypertension et des réductions correspondantes de maladies cardiovasculaires et de mortalité totale associées à l’amorce des initiatives liées à l’hypertension. Par conséquent, le Canada se taille une place comme chef de file mondial de la prévention, du traitement et du contrôle de l’hypertension.
Figures

Similar articles
-
Hypertension prevention and control in Canada.J Am Soc Hypertens. 2008 Mar-Apr;2(2):97-105. doi: 10.1016/j.jash.2007.10.001. J Am Soc Hypertens. 2008. PMID: 20409891
-
The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies?Curr Opin Cardiol. 2010 Jul;25(4):366-72. doi: 10.1097/HCO.0b013e32833a3632. Curr Opin Cardiol. 2010. PMID: 20502323 Review.
-
Canada Chair in hypertension prevention and control: a pilot project.Can J Cardiol. 2007 May 15;23(7):557-60. doi: 10.1016/s0828-282x(07)70800-0. Can J Cardiol. 2007. PMID: 17534462 Free PMC article.
-
Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.CMAJ. 1999 May 4;160(9 Suppl):S1-6. CMAJ. 1999. PMID: 10333847 Free PMC article.
-
Canadian national high blood pressure prevention and control strategy.Can J Cardiol. 2000 Sep;16(9):1087-93. Can J Cardiol. 2000. PMID: 11021952 Review. English, French.
Cited by
-
Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension.Can J Cardiol. 2010 May;26(5):e158-63. doi: 10.1016/s0828-282x(10)70383-4. Can J Cardiol. 2010. PMID: 20485695 Free PMC article. Review.
-
Prevalence of the use of antihypertensive medications in Greenland: a study of quality of care amongst patients treated with antihypertensive drugs.Int J Circumpolar Health. 2012;71:18834. doi: 10.3402/ijch.v71i0.18834. Epub 2012 Jun 13. Int J Circumpolar Health. 2012. PMID: 22957317 Free PMC article.
-
[Control of arterial hypertension: a pending issueControle da hipertensão arterial: um assunto inacabado].Rev Panam Salud Publica. 2022 Sep 16;46:e147. doi: 10.26633/RPSP.2022.147. eCollection 2022. Rev Panam Salud Publica. 2022. PMID: 36133428 Free PMC article. Spanish.
-
Know your blood pressure; the theme of world hypertension day 2014.Iran J Public Health. 2014 Aug;43(8):1154-6. Iran J Public Health. 2014. PMID: 25927049 Free PMC article. No abstract available.
-
Changes in hypertension treatment in the yaroslavl region of Russia: improvements observed between 2 cross-sectional surveys.J Clin Hypertens (Greenwich). 2013 Dec;15(12):918-24. doi: 10.1111/jch.12214. Epub 2013 Oct 9. J Clin Hypertens (Greenwich). 2013. PMID: 24118731 Free PMC article.
References
-
- Lawes CM, Vander HS, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8. - PubMed
-
- Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: A systematic review. J Hypertens. 2004;22:11–9. - PubMed
-
- Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–62. - PubMed
-
- Kannel WB, Wolf PA, Verter J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA. 1970;214:301–10. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials